Patents by Inventor Harvey Schneier

Harvey Schneier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20240115656
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: December 15, 2023
    Publication date: April 11, 2024
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20230263854
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: March 16, 2023
    Publication date: August 24, 2023
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20220111001
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: December 20, 2021
    Publication date: April 14, 2022
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20190282655
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 19, 2019
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20190022173
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: September 20, 2018
    Publication date: January 24, 2019
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20180147253
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: January 25, 2018
    Publication date: May 31, 2018
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20170281722
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 5, 2017
    Applicant: Forest Laboratories Holdings Limited
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20160206686
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 21, 2016
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Treatment of Chronic Constipation
    Publication number: 20140349948
    Abstract: The invention provides methods for treating a patient with chronic constipation by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: December 23, 2013
    Publication date: November 27, 2014
    Applicants: Forest Laboratories Holdings Limited, Ironwood Pharmaceuticals, Inc.
    Inventors: Jeffrey Johnston, Angelika Fretzen, Steven Witowski, Alfredo Grossi, Hong Zhao, Bernard Joseph Lavins, Mahendra Dedhiya, Harvey Schneier
  • Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Publication number: 20140162963
    Abstract: The invention provides methods for treating a patient with constipation-predominant irritable bowel syndrome by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: September 9, 2011
    Publication date: June 12, 2014
    Applicants: Forest Laboratories Holdings Limited, Ironwood Pharmaceuticals, Inc.
    Inventors: Jeffrey Johnston, Bernard Joseph Lavins, Harvey Schneier
  • Linaclotide for the Treatment of Chronic Constipation
    Publication number: 20130059797
    Abstract: The invention provides methods for treating a patient with chronic constipation by administering a therapeutically effective dose of linaclotide.
    Type: Application
    Filed: November 3, 2010
    Publication date: March 7, 2013
    Applicants: Forest Laboratories Holdings Limited, Ironwood Pharmaceuticals ,Inc.
    Inventors: Jeffrey Johnston, Angelika Fretzen, Steven Witowski, Alfredo Grossi, Hong Zhao, Bernard Joseph Lavins, Mahendra Dedhiya, Harvey Schneier